IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 149 filers reported holding IMPAX LABORATORIES INC in Q2 2013. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $81,346,000 | +18.1% | 4,182,312 | +1.1% | 0.02% | +20.0% |
| Q4 2017 | $68,873,000 | +4188.5% | 4,136,625 | +3313.1% | 0.02% | – |
| Q4 2016 | $1,606,000 | +26.9% | 121,200 | +127.0% | 0.00% | – |
| Q3 2016 | $1,266,000 | +60.7% | 53,402 | +211.2% | 0.00% | – |
| Q2 2015 | $788,000 | -75.0% | 17,161 | -74.4% | 0.00% | -100.0% |
| Q1 2015 | $3,148,000 | +21.0% | 67,166 | -18.2% | 0.00% | 0.0% |
| Q4 2014 | $2,601,000 | +100.4% | 82,103 | +49.9% | 0.00% | – |
| Q3 2014 | $1,298,000 | -85.3% | 54,755 | -81.5% | 0.00% | -100.0% |
| Q2 2014 | $8,859,000 | +35.3% | 295,398 | +19.2% | 0.00% | 0.0% |
| Q1 2014 | $6,546,000 | +334.1% | 247,779 | +313.1% | 0.00% | – |
| Q4 2013 | $1,508,000 | +359.8% | 59,980 | +274.9% | 0.00% | – |
| Q3 2013 | $328,000 | +2.8% | 16,000 | 0.0% | 0.00% | – |
| Q2 2013 | $319,000 | – | 16,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $98,362,000 | 8.33% |
| Krensavage Asset Management, LLC | 587,882 | $18,824,000 | 6.75% |
| Hound Partners | 6,757,558 | $216,377,000 | 5.88% |
| Asymmetry Capital Management, L.P. | 62,050 | $1,987,000 | 5.18% |
| Orbimed Advisors | 6,776,100 | $216,971,000 | 2.28% |
| Pennant Capital Management, LLC | 2,083,074 | $66,700,000 | 1.90% |
| UNIVERSITY OF NOTRE DAME DU LAC | 41,104 | $1,316,000 | 1.62% |
| Tygh Capital Management, Inc. | 137,975 | $4,418,000 | 1.29% |
| JW Asset Management, LLC | 53,373 | $1,709,000 | 1.12% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,784 | $8,863,000 | 0.93% |